✦ LIBER ✦

Evaluation of safety profile of black shilajit after 91 days repeated administration in rats

✍ Scribed by C Velmurugan; B Vivek; E Wilson; T Bharathi; T Sundaram

Book ID: 117806157
Publisher: Medknow Publications
Year: 2012
Tongue: English
Weight: 581 KB
Volume: 2
Category: Article
ISSN: 2221-1691
DOI: 10.1016/s2221-1691(12)60043-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicological evaluation of azumolene af

Toxicological evaluation of azumolene after repeated intraperitoneal administration in rats

✍ Paula Lima Do Carmo; Gisele Zapata-Sudo; Margarete Manhães Trachez; Maria Das Gr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Safety evaluation of benzophenone-3 afte

Safety evaluation of benzophenone-3 after dermal administration in rats

✍ Chukwuemeka S. Okereke; Stephen A. Barat; Mohamed S. Abdel-Rahman 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 660 KB

290 Anatomopathologic changes in sprague

290 Anatomopathologic changes in sprague Dawley rats after 14 days repeated administration of human recombinant erythropoietin

✍ D. Fuentes; M. Arteaga; O. Hernández; A. Casacó; A. Thomas; Y. Rivero; Y. Torres 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Toxicokinetics of naringin, a putative a

Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats

✍ Menghua Liu; Cuiping Yang; Wei Zou; Xiaoling Guan; Wenyan Zheng; Li Lai; Siqi Fa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Evaluation of Lactational Parameters aft

Evaluation of Lactational Parameters after Alcohol Administration for Four Days during Early or Midlactation in the Rat

✍ Marappa G. Subramanian 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

Development of polyethylene glycol-conju

Development of polyethylene glycol-conjugated alendronate, a novel nitrogen-containing bisphosphonate derivative: Evaluation of absorption, safety, and effects after intrapulmonary administration in rats

✍ Hidemasa Katsumi; Miki Takashima; Jun-Ichi Sano; Kazushi Nishiyama; Noriko Kitam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

Bisphosphonates are widely used for the treatment of bone diseases, including hypercalcemia and osteoporosis. However, the bioavailability (BA) of orally administered bisphosphonates is low, at approximately 0.9%-1.8%. In addition, the oral administration of bisphosphonates is associated with mucosa